stars 1 stars 2 stars 3

APCER Life Sciences, established in 2007, is a trusted global leader in pharmacovigilance, medical information, medical writing, and regulatory affairs. We are dedicated to enhancing health outcomes and firmly believe that by working together for better health, we can forge a future where well-being is prioritized for all. Our expert teams, composed entirely of healthcare professionals, deliver customized solutions that support the entire product lifecycle—from development to post-market compliance. Our subject matter expertise in a wide range of therapeutic areas means we are well-equipped to handle complexity, including rare disease and advanced therapies/cell and gene therapies. What sets APCER apart is our unwavering commitment to excellence and patient safety. We take on end-to-end accountability, ensuring consistent quality across all service offerings. With a presence across North America, Europe, and Asia, we navigate global regulations with precision. Our customer-first mindset enables us to build enduring partnerships, allowing us to adapt our scalable solutions to meet the evolving needs of pharmaceutical and biotech companies as they grow. APCER Life Sciences - Together for Better Health!

APCER Life Sciences Questions

The APCER Life Sciences annual revenue was $195 million in 2026.

Dan Diaz is the VP, Business Development and Client Services of APCER Life Sciences.

548 people are employed at APCER Life Sciences.

The NAICS codes for APCER Life Sciences are [325, 32, 3254, 32541].

The SIC codes for APCER Life Sciences are [874, 87].

Top APCER Life Sciences Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users